Telomerase activity in bilharzial bladder cancer: Prognostic implications

Citation
Im. Abdel-salam et al., Telomerase activity in bilharzial bladder cancer: Prognostic implications, UROL ONCOL, 6(4), 2001, pp. 149-153
Citations number
27
Categorie Soggetti
Urology & Nephrology
Journal title
UROLOGIC ONCOLOGY
ISSN journal
10781439 → ACNP
Volume
6
Issue
4
Year of publication
2001
Pages
149 - 153
Database
ISI
SICI code
1078-1439(200107/08)6:4<149:TAIBBC>2.0.ZU;2-A
Abstract
Background: Bladder cancer is a common malignancy in Egypt and other develo ping countries in which infection with Schistosoma haematobium is prevalent . Bladder cancer caused by bilharziasis has different clinical and biologic al characters than that observed in the western world. In this study. we us ed the TRAP technique to estimate telomerase activity in bilharzial bladder cancer specimens and we correlated the findings with other clinical and pa thological findings. Patients and methods: Bladder cancer specimens were ob tained from 57 patients who underwent radical cystectomy and pathological d iagnosis was obtained in all patients. Tissue samples were frozen in liquid nitrogen and stored at -80 degreesC. Telomerase activity by PCR-ELISA tech nique was measured using TRAP technique. Results: Our patient group include d 45 malts and 12 females with a median age of 49 years. The majority of ou r patients (35/57) have squamous histology and they have proven bilharzial history shown in the pathology specimens. Stage P3b was encountered in 29/5 7 patients whereas thirty five patients have grade II tumors. The majority of our patients (41/57) were negative for pelvic nodes metastases. Telomera se activity was detected in 27/57 patients (47.4%). The mean level of telom erase was 0.85 +/-0.77 in positive patients and 0.029 +/-0.025 in negative patients. The expression of telomerase and its mean level in patients above age of 60, in males and in those with squamous pathology, higher grade of tumors or positive node was higher than those without hut the difference di d not reach statistical significance (P > 0.05). Alternatively. expression was significantly higher in those with stages (P1-P3a) compared with P3b-P4 a disease stages (66.6% vs. 37.1, P=0.03). Conclusion: Telomerase activity is increased in bilharzial bladder cancer although to a lesser degree than that reported for TCC in the western world, which could be explained, by di fferent biological behavior or different assay methods. Further larger stud ies with more number of patients are still needed to determine its potentia l value for early detection and possible use as a therapeutic target. (C) 2 001 Elsevier Science Inc. All rights reserved.